Clinical Trials Browser

Phase 1/2 × OTHER × enfortumab vedotin × Clear all

NCT06434350 2026-03-02

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Phase 1/2 Recruiting

Advanced Bladder Cancer

NCT06470282 2026-02-18

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Phase 1/2 Recruiting

Urinary Bladder Neoplasms

NCT06394570 2025-09-15

STAR-EV

Phase 1/2 Recruiting

Urinary Bladder Neoplasms